Evidence map›Paper›PMID 37407728›Full record

ReviewBone marrow transplantation2023

The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT.

Amanda Casirati, Isabel Salcedo, Emanuele Cereda, Christian Chabannon, Annalisa Ruggeri, Jurgen Kuball, Ruth Clout, Jarl E Mooyaart, Michelle Kenyon, Riccardo Caccialanza and 4 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Bone marrow transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. A liberalized diet does not improve caloric intake during neutropenia in patients undergoing hematopoietic stem cell transplants: A prospective randomized controlled trial.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2025
    Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 6 countries.

Amanda Casirati *Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID 0000-0002-6005-5068
Isabel SalcedoDepartment of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
Emanuele CeredaClinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID 0000-0002-0747-1951
Christian ChabannonCentre de Thérapie Cellulaire & Centre d'Investigations Cliniques en Biothérapies Inserm CBT-1409, Institut Paoli-Calmettes, Marseille, France.ORCID 0000-0002-3755-4889
Annalisa RuggeriHematology and BMT Unit, San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0002-7261-2765
Jurgen KuballDepartment of Hematology and Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-3914-7806
Ruth CloutDepartment of Haematology and Transplant Unit, The Christie Hospital, Manchester, United Kingdom.
Jarl E MooyaartEBMT Statistical Unit, Leiden, The Netherlands.
Michelle KenyonDepartment of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.ORCID 0000-0002-1859-6178
Riccardo Caccialanza *Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID 0000-0002-9379-3569
Paolo PedrazzoliDepartment of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy. p.pedrazzoli@smatteo.pv.it.ORCID 0000-0002-9419-7160
Annika M KischDepartment of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden and Institute of Health Sciences, Lund University, Lund, Sweden.ORCID 0000-0002-1536-3926
Cellular Therapy and Immunobiology Working Party
Nurses Group of the EBMT
Policlinico San Matteo Fondazione · ITEuropean Society for Blood and Marrow Transplantation · NLHospital Universitario Puerta de Hierro Majadahonda · ESInserm · FRKing's College Hospital NHS Foundation Trust · GBLund University · SESan Raffaele University of Rome · ITThe Christie Hospital · GBUniversity Medical Center Utrecht · NLUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malnutrition is the most common comorbidity during the continuum of hematopoietic stem cell transplant (HSCT) and negatively impacts clinical outcomes, response to therapy, quality of life, and costs. The intensive conditioning regimen administered before transplant causes inflammatory damages to the gastrointestinal system, which themselves contribute to trigger graft versus host disease (GvHD) in the allogeneic setting. GvHD and other post-transplant complications such as infections adversely affect food intake and gut absorption of nutrients. Consequently, patients exhibit signs of malnutrition such as weight loss and muscle wasting, thus triggering a "vicious circle" that favours additional complications. Among HSCT centres, there is marked variability in nutritional care, from screening for malnutrition to nutritional intervention. The present paper, elaborated by the Cellular Therapy and Immunobiology Working Party and the Nurses Group of the European Society for Blood and Marrow Transplantation, aims at defining a roadmap that identifies the main nutritional critical issues in the field of HSCT. This document will be propaedeutic to the development of clinical algorithms to counteract risk factors of malnutrition, based on scientific evidence and shared among HSCT centres, and thus maximize transplant outcomes.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationMalnutritionNursesBone MarrowHumansQuality of LifeTransplantation Conditioning

Identifiers

PMID37407728
OpenAlexW4383224374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.